|
Q2 2025
|
55 |
2,923,924 |
GUARDANT HEALTH INC, CARIS LIFE SCIENCES INC, NBIX, NOVOCURE LTD
|
13F-HR
|
8/14/2025 |
000142050625002183 |
|
Q1 2025
|
64 |
2,844,802 |
GUARDANT HEALTH INC, NOVOCURE LTD, NBIX, BRIDGEBIO PHARMA INC
|
13F-HR
|
5/15/2025 |
000142050625001293 |
|
Q4 2024
|
73 |
3,372,652 |
GUARDANT HEALTH INC, BRIDGEBIO PHARMA INC, NOVOCURE LTD, NBIX
|
13F-HR
|
2/14/2025 |
000192093825000002 |
|
Q3 2024
|
81 |
3,527,985 |
GUARDANT HEALTH INC, BRIDGEBIO PHARMA INC, DEXCOM INC, NOVOCURE LTD
|
13F-HR
|
11/14/2024 |
000192093824000006 |
|
Q2 2024
|
75 |
3,187,767 |
GUARDANT HEALTH INC, BRIDGEBIO PHARMA INC, DEXCOM INC, NOVOCURE LTD
|
13F-HR
|
8/14/2024 |
000142050624001566 |
|
Q1 2024
|
70 |
3,102,773 |
BRIDGEBIO PHARMA INC, GUARDANT HEALTH INC, EXACT SCIENCES CORP, NOVOCURE LTD
|
13F-HR
|
5/15/2024 |
000192093824000004 |
|
Q4 2023
|
72 |
2,722,670 |
BRIDGEBIO PHARMA INC, GUARDANT HEALTH INC, ASCENDIS PHARMA A/S, EXACT SCIENCES CORP
|
13F-HR
|
2/14/2024 |
000142050624000478 |
|
Q3 2023
|
86 |
3,164,360 |
GUARDANT HEALTH INC, BRIDGEBIO PHARMA INC, NOVOCURE LTD, ASCENDIS PHARMA A/S
|
13F-HR
|
11/14/2023 |
000142050623002213 |
|
Q2 2023
|
81 |
3,060,428 |
GUARDANT HEALTH INC, BRIDGEBIO PHARMA INC, EXACT SCIENCES CORP, NOVOCURE LTD
|
13F-HR
|
8/14/2023 |
000142050623001695 |
|
Q1 2023
|
81 |
3,032,008 |
GUARDANT HEALTH INC, EXACT SCIENCES CORP, BRIDGEBIO PHARMA INC, NANOSTRING TECHNOLOGIES INC
|
13F-HR
|
5/15/2023 |
000090514823000454 |
|
Q4 2022
|
88 |
2,984,124 |
GUARDANT HEALTH INC, EXACT SCIENCES CORP, NANOSTRING TECHNOLOGIES INC, NOVOCURE LTD
|
13F-HR
|
2/14/2023 |
000142050623000696 |